Literature DB >> 2425755

Treatment of chronic urticaria with PUVA or UVA plus placebo: a double-blind study.

J H Olafsson, O Larkö, G Roupe, G Granerus, U Bengtsson.   

Abstract

Chronic urticaria is a disease for which the available range of treatment modalities is limited. Ultraviolet radiation has recently been shown to affect histamine release from mast cells. We therefore studied the effects of PUVA and UVA on chronic urticaria. Nineteen patients took part in the study, which was designed as a randomized double-blind study. Eleven patients received PUVA, and 8 received UVA plus a placebo. In the PUVA group, 7 patients showed improvement, 3 noticed no change, and 1 became worse. In the group that received UVA plus placebo, 5 patients experienced an improvement, whereas the other 3 showed no change. The differences between the groups were not statistically significant. However, the probability of achieving this degree of improvement in both groups just by chance is less than 1%. Consequently, the improvement noted could have been due to either UVA alone or a placebo effect. It is concluded that PUVA is not better than UVA in the treatment of chronic urticaria.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425755     DOI: 10.1007/bf00412929

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  14 in total

1.  Urinary excretion of histamine, methylhistamine and methylimidazoleacetic acids in man under standardized dietary conditions.

Authors:  G Granerus
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  The suggestive effect of placebo on the intensity of chronic urticaria.

Authors:  E Rudzki; W Borkowski; K Czubalski
Journal:  Acta Allergol       Date:  1970-04

3.  The effect of terfenadine on dermographic wealing.

Authors:  L B Krause; S Shuster
Journal:  Br J Dermatol       Date:  1984-01       Impact factor: 9.302

4.  Studies on histamine metabolism in mastocytosis.

Authors:  G Granerus; J H Olafsson; G Roupe
Journal:  J Invest Dermatol       Date:  1983-05       Impact factor: 8.551

5.  PUVA-treatment for solar urticaria and persistent light reaction.

Authors:  E Hölzle; C Hofmann; G Plewig
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

6.  Ultraviolet A phototherapy in the prophylaxis of solar urticaria.

Authors:  J D Bernhard; K Jaenicke; K Momtaz-T; J A Parrish
Journal:  J Am Acad Dermatol       Date:  1984-01       Impact factor: 11.527

7.  A case of chronic urticaria and vitiligo, associated with thyroiditis, treated with PUVA.

Authors:  K Midelfart; D Moseng; G Kavli; S E Stenvold; G Volden
Journal:  Dermatologica       Date:  1983

8.  Urinary excretion of histamine, methylhistamine (1-MeHi) and methylimidazoleacetic acid (MeImAA) in mastocytosis: comparison of new HPLC methods with other present methods.

Authors:  G Granerus; U Wass
Journal:  Agents Actions       Date:  1984-04

9.  Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa.

Authors:  D Vella Briffa; R A Eady; M P James; S Gatti; S S Bleehen
Journal:  Br J Dermatol       Date:  1983-07       Impact factor: 9.302

10.  Decreased urinary histamine metabolite after successful PUVA treatment of urticaria pigmentosa.

Authors:  G Granerus; G Roupe; G Swanbeck
Journal:  J Invest Dermatol       Date:  1981-01       Impact factor: 8.551

View more
  2 in total

1.  Ultraviolet radiation abolishes cutaneous nerve stainings with two axon-specific antibodies in guinea-pig skin.

Authors:  K Danno; Q K Sayeed; Y Horiguchi; S Imamura
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

Review 2.  Urticaria. Recognition, causes and treatment.

Authors:  A D Ormerod
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.